+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Cell Dissociation Market by Product (Enzymatic Dissociation Products, Instruments & Accessories, Non-Enzymatic Dissociation Products), Type (Cell Detachment, Tissue Dissociation), Tissue, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5592068
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cell Dissociation Market size was estimated at USD 759.32 million in 2023, USD 878.60 million in 2024, and is expected to grow at a CAGR of 16.91% to reach USD 2,267.64 million by 2030.

Cell dissociation, also known as cell disruption or fractionation, consists of a process by which cells is broken down into smaller parts for further study or analysis. The growth of the cell dissociation market is primarily driven by the prevalence of cell-based research initiated by many pharmaceutical and biotechnology companies. Cell dissociation is vital in biopharmaceutical research as it is directly involved in drug development and pathophysiology elucidation. The biopharmaceutical industry is a fast-growing area of the pharmaceutical industry with major implications for healthcare. As a result of the high efficacy and safety of these treatments, opportunities in biopharmaceuticals have grown significantly during the last decade. However, isolation and purification of cell organelles integrate expensive products, and automated or semi-automated benchtop instruments are more expensive than traditional methods, which may limit product adoption, further restraining market growth. Nevertheless, increasing funding for stem cell research by government bodies and companies is expected to offer new growth opportunities for the industry.

Regional Insights

The market is growing due to increased spending by biopharmaceutical companies on R&D operations across North America, Europe, and Asia-Pacific regions. North America has dominated the market for the last few years, attributed to the rise in investment initiatives by the U.S. government, increasing chronic disease incidences, such as cancer, along with high-quality infrastructure for clinical & laboratory research in the U.S. and Canada. The Asia Pacific region is expected to grow rapidly during the forecast period due to the rising demand for novel therapeutics in the countries such as China, Japan, and India. Furthermore, increasing R&D investments and rapid infrastructural development are key factors fueling the market growth in China and India. Asia-Pacific’s pharmaceutical market has remained highly competitive and fragmented, with numerous small manufacturers competing for market shares. From an economic and policy standpoint, government support is expected to drive innovation in life sciences research and the growth of the pharmaceutical and biopharmaceutical sector. In Europe, several companies from the U.K. and Germany are investing heavily to develop a treatment for various chronic diseases such as heart diseases and cancer, which is expected to contribute toward market growth across Europe.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Dissociation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Dissociation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Dissociation Market, highlighting leading vendors and their innovative profiles. These include Abeomics Inc., AcceGen, ACROBiosystems Group, ALSTEM, AMS Biotechnology, Becton, Dickinson and Company, Bio-Techne Corporation, Biogenuix Medsystems Pvt. Ltd., Capricorn Scientific, Captivate Bio, LLC, Cell Signaling Technology, Inc., Cellseco Ltd., Cellsystems Gmbh, Celprogen Corporation, Central Drug House. (P) Ltd., Corning Inc., Creative Bioarray, Cytori Therapeutics Inc., Diagnocine, F. Hoffmann-La Roche Ltd., FlowMetric, Inc., Gemini BioProducts LLC, Genaxxon bioscience GmbH, Genlantis Inc., Genomics, Inc., HiMedia Laboratories Private Limited, Innovative Cell Technologies, Inc., Krackeler Scientific, Inc., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, MP Biomedicals, LLC, Nacalai Tesque, Inc., Neuromics, Nordmark Pharma GmbH, PAN-Biotech GmbH, PELOBIOTECH GmbH, PromoCell GmbH, Protein Ark Ltd. by CalibreScientific, REPROCELL Inc., RWD Life Science Co., Ltd., Sartorius AG, ScienCell Research Laboratories, Inc., Singleron Biotechnologies GmbH, STEMCELL Group, Stemmera Inc., Tebubio, Thermo Fisher Scientific Inc., VitaCyte, LLC, VWR International, LLC, and Worthington Biochemical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Dissociation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Enzymatic Dissociation Products
      • Collagenase
      • DNase
      • Elastase
      • Hyaluronidase
      • Papain
      • Trypsin
    • Instruments & Accessories
    • Non-Enzymatic Dissociation Products
  • Type
    • Cell Detachment
    • Tissue Dissociation
  • Tissue
    • Connective Tissues
    • Epithelial Tissues
    • Skeletal & Muscles Tissues
  • End-User
    • Pharmaceutical & Biotechnology Companies
    • Research & Academics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Cell Dissociation Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Dissociation Market?
  3. What are the technology trends and regulatory frameworks in the Cell Dissociation Market?
  4. What is the market share of the leading vendors in the Cell Dissociation Market?
  5. Which modes and strategic moves are suitable for entering the Cell Dissociation Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cell Dissociation Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cell based research activities across pharmaceutical and biopharmaceutical companies
5.1.1.2. Rising incidence and prevalence of chronic and infectious diseases
5.1.1.3. Availability of government funding for stem-cell research activities
5.1.2. Restraints
5.1.2.1. High cost of tissue and cell based procedures
5.1.3. Opportunities
5.1.3.1. Ongoing introduction of advanced cell dissociation products
5.1.3.2. Rising regulatory approvals for the cell dissociation developments
5.1.4. Challenges
5.1.4.1. Limited infrastructure for the cell-based research in underdeveloped countries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cell Dissociation Market, by Product
6.1. Introduction
6.2. Enzymatic Dissociation Products
6.3.1. Collagenase
6.3.2. DNase
6.3.3. Elastase
6.3.4. Hyaluronidase
6.3.5. Papain
6.3.6. Trypsin
6.3. Instruments & Accessories
6.4. Non-Enzymatic Dissociation Products
7. Cell Dissociation Market, by Type
7.1. Introduction
7.2. Cell Detachment
7.3. Tissue Dissociation
8. Cell Dissociation Market, by Tissue
8.1. Introduction
8.2. Connective Tissues
8.3. Epithelial Tissues
8.4. Skeletal & Muscles Tissues
9. Cell Dissociation Market, by End-User
9.1. Introduction
9.2. Pharmaceutical & Biotechnology Companies
9.3. Research & Academics
10. Americas Cell Dissociation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Dissociation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cell Dissociation Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Agilent Announces Acquisition of Company Behind Electron Capture Dissociation Technology
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia
13.3.2.2. Applied Cells Enters into a Supply Agreement with STEMCELL Technologies on Reagent Kits for Use in a Next-Generation Solution for Cell Separation
13.3.3. New Product Launch & Enhancement
13.3.3.1. LevitasBio Unveils LeviPrep and LeviSelect Product Lines
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abeomics Inc.
14.1.2. AcceGen
14.1.3. ACROBiosystems Group
14.1.4. ALSTEM
14.1.5. AMS Biotechnology
14.1.6. Becton, Dickinson and Company
14.1.7. Bio-Techne Corporation
14.1.8. Biogenuix Medsystems Pvt. Ltd.
14.1.9. Capricorn Scientific
14.1.10. Captivate Bio, LLC
14.1.11. Cell Signaling Technology, Inc.
14.1.12. Cellseco Ltd.
14.1.13. Cellsystems Gmbh
14.1.14. Celprogen Corporation
14.1.15. Central Drug House. (P) Ltd.
14.1.16. Corning Inc.
14.1.17. Creative Bioarray
14.1.18. Cytori Therapeutics Inc.
14.1.19. Diagnocine
14.1.20. F. Hoffmann-La Roche Ltd.
14.1.21. FlowMetric, Inc.
14.1.22. Gemini BioProducts LLC
14.1.23. Genaxxon bioscience GmbH
14.1.24. Genlantis Inc.
14.1.25. Genomics, Inc.
14.1.26. HiMedia Laboratories Private Limited
14.1.27. Innovative Cell Technologies, Inc.
14.1.28. Krackeler Scientific, Inc.
14.1.29. Merck KGaA
14.1.30. Miltenyi Biotec B.V. & Co. KG
14.1.31. MP Biomedicals, LLC
14.1.32. Nacalai Tesque, Inc.
14.1.33. Neuromics
14.1.34. Nordmark Pharma GmbH
14.1.35. PAN-Biotech GmbH
14.1.36. PELOBIOTECH GmbH
14.1.37. PromoCell GmbH
14.1.38. Protein Ark Ltd. by CalibreScientific
14.1.39. REPROCELL Inc.
14.1.40. RWD Life Science Co., Ltd.
14.1.41. Sartorius AG
14.1.42. ScienCell Research Laboratories, Inc.
14.1.43. Singleron Biotechnologies GmbH
14.1.44. STEMCELL Group
14.1.45. Stemmera Inc.
14.1.46. Tebubio
14.1.47. Thermo Fisher Scientific Inc.
14.1.48. VitaCyte, LLC
14.1.49. VWR International, LLC
14.1.50. Worthington Biochemical Corporation
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. CELL DISSOCIATION MARKET RESEARCH PROCESS
FIGURE 2. CELL DISSOCIATION MARKET SIZE, 2023 VS 2030
FIGURE 3. CELL DISSOCIATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CELL DISSOCIATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CELL DISSOCIATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CELL DISSOCIATION MARKET DYNAMICS
FIGURE 7. CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CELL DISSOCIATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. CELL DISSOCIATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2023 VS 2030 (%)
FIGURE 12. CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CELL DISSOCIATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. CELL DISSOCIATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CELL DISSOCIATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. CELL DISSOCIATION MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CELL DISSOCIATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CELL DISSOCIATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 8. CELL DISSOCIATION MARKET SIZE, BY COLLAGENASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CELL DISSOCIATION MARKET SIZE, BY DNASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CELL DISSOCIATION MARKET SIZE, BY ELASTASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CELL DISSOCIATION MARKET SIZE, BY HYALURONIDASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CELL DISSOCIATION MARKET SIZE, BY PAPAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CELL DISSOCIATION MARKET SIZE, BY TRYPSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CELL DISSOCIATION MARKET SIZE, BY NON-ENZYMATIC DISSOCIATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 17. CELL DISSOCIATION MARKET SIZE, BY CELL DETACHMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CELL DISSOCIATION MARKET SIZE, BY TISSUE DISSOCIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 20. CELL DISSOCIATION MARKET SIZE, BY CONNECTIVE TISSUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CELL DISSOCIATION MARKET SIZE, BY EPITHELIAL TISSUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CELL DISSOCIATION MARKET SIZE, BY SKELETAL & MUSCLES TISSUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. CELL DISSOCIATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. CELL DISSOCIATION MARKET SIZE, BY RESEARCH & ACADEMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. CANADA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. CANADA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 44. CANADA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 46. CANADA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. MEXICO CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. MEXICO CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. CHINA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. CHINA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 71. CHINA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. CHINA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 73. CHINA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. INDIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. INDIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 76. INDIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 78. INDIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. JAPAN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. JAPAN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 86. JAPAN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 88. JAPAN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. THAILAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. THAILAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 116. THAILAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 118. THAILAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. DENMARK CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 134. DENMARK CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. EGYPT CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. EGYPT CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 137. EGYPT CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. FINLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. FINLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 142. FINLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 144. FINLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. GERMANY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. GERMANY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. ITALY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 162. ITALY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 164. ITALY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. NORWAY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. NORWAY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 179. NORWAY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. POLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. POLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 182. POLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 184. POLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. QATAR CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. QATAR CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 187. QATAR CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 189. QATAR CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. SPAIN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. SPAIN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 209. SPAIN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. TURKEY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. TURKEY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. CELL DISSOCIATION MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 236. CELL DISSOCIATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 237. CELL DISSOCIATION MARKET LICENSE & PRICING

Companies Mentioned

  • Abeomics Inc.
  • AcceGen
  • ACROBiosystems Group
  • ALSTEM
  • AMS Biotechnology
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Biogenuix Medsystems Pvt. Ltd.
  • Capricorn Scientific
  • Captivate Bio, LLC
  • Cell Signaling Technology, Inc.
  • Cellseco Ltd.
  • Cellsystems Gmbh
  • Celprogen Corporation
  • Central Drug House. (P) Ltd.
  • Corning Inc.
  • Creative Bioarray
  • Cytori Therapeutics Inc.
  • Diagnocine
  • F. Hoffmann-La Roche Ltd.
  • FlowMetric, Inc.
  • Gemini BioProducts LLC
  • Genaxxon bioscience GmbH
  • Genlantis Inc.
  • Genomics, Inc.
  • HiMedia Laboratories Private Limited
  • Innovative Cell Technologies, Inc.
  • Krackeler Scientific, Inc.
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • MP Biomedicals, LLC
  • Nacalai Tesque, Inc.
  • Neuromics
  • Nordmark Pharma GmbH
  • PAN-Biotech GmbH
  • PELOBIOTECH GmbH
  • PromoCell GmbH
  • Protein Ark Ltd. by CalibreScientific
  • REPROCELL Inc.
  • RWD Life Science Co., Ltd.
  • Sartorius AG
  • ScienCell Research Laboratories, Inc.
  • Singleron Biotechnologies GmbH
  • STEMCELL Group
  • Stemmera Inc.
  • Tebubio
  • Thermo Fisher Scientific Inc.
  • VitaCyte, LLC
  • VWR International, LLC
  • Worthington Biochemical Corporation

Methodology

Loading
LOADING...

Table Information